Holen Sie sich die Stockscreener-App
1.54
5.52%
-0.09
Handel nachbörslich:
1.54
Schlusskurs vom Vortag:
$1.63
Offen:
$1.6
24-Stunden-Volumen:
280.76K
Relative Volume:
0.04
Marktkapitalisierung:
$22.51M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.90M
KGV:
-0.00748
EPS:
-206.0125
Netto-Cashflow:
$-12.75M
1W Leistung:
-2.53%
1M Leistung:
+63.60%
6M Leistung:
+38.74%
1J Leistung:
-32.75%
1-Tages-Spanne:
$1.53
$1.615
1-Wochen-Bereich:
$1.52
$1.84
52-Wochen-Spanne:
$0.6138
$2.35
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Firmenname
Allarity Therapeutics Inc
Sektor
Branche
Telefon
401-426-4664
Adresse
24 SCHOOL ST., 2ND FLOOR, BOSTON
Vergleichen Sie ALLR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
1.54 | 23.83M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Eingeleitet | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Aktie (ALLR) Neueste Nachrichten
Allarity Therapeutics Secures $2.5M Through Private Placement - MSN
Allarity presents new Phase 2 clinical data for Stenoparib - TipRanks
Using data tools to time your Allarity Therapeutics Inc. exitWeekly Trade Recap & Precise Buy Zone Identification - newser.com
Allarity Therapeutics Presents New Phase 2 Clinical Data - GlobeNewswire
Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months - GlobeNewswire Inc.
Is a relief rally coming for Allarity Therapeutics Inc. holdersMarket Volume Report & Smart Money Movement Alerts - newser.com
What MACD and RSI say about Allarity Therapeutics Inc.July 2025 Sector Moves & Real-Time Chart Pattern Alerts - newser.com
Allarity Therapeutics, Inc. announced that it expects to receive $10 million in funding - MarketScreener
How to use a screener to detect Allarity Therapeutics Inc. breakoutsPortfolio Return Report & Smart Allocation Stock Tips - newser.com
Does Allarity Therapeutics Inc. qualify in momentum factor screening2025 Earnings Surprises & Reliable Entry Point Trade Alerts - newser.com
Breakout Watch: Is Allarity Therapeutics Inc. trading at a discountJuly 2025 Recap & Daily Oversold Bounce Ideas - خودرو بانک
Aug Analyst Calls: What is Allarity Therapeutics Incs 5 year growth outlookVolume Spike & Real-Time Volume Trigger Notifications - خودرو بانک
Whats the fair value of MBX Biosciences Inc stockJuly 2025 Update & Expert-Curated Trade Recommendations - خودرو بانک
Published on: 2025-09-18 11:59:38 - newser.com
Analyzing net buyer seller activity in Allarity Therapeutics Inc.2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com
Is Allarity Therapeutics Inc. building a consolidation baseInflation Watch & Verified Technical Signals - newser.com
Candlestick signals on Allarity Therapeutics Inc. stock today2025 Geopolitical Influence & Daily Stock Trend Watchlist - newser.com
Automated trading signals detected on Allarity Therapeutics Inc.Portfolio Growth Summary & Real-Time Chart Pattern Alerts - newser.com
Allarity Therapeutics CEO to Present at Biomarkers & Precision Medicine 2025 - GlobeNewswire
Phase 2 Dual PARP/WNT Inhibitor: Allarity CEO to Present Breakthrough Biomarker Data in London - Stock Titan
Activity Recap: Will Allarity Therapeutics Inc. stock benefit from M&ATrade Ideas & Technical Buy Zone Confirmations - khodrobank.com
How hedge fund analytics apply to Allarity Therapeutics Inc. stock2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Day Trade: Is Allarity Therapeutics Inc stock good for income investorsJuly 2025 Review & Stock Market Timing Techniques - khodrobank.com
Swing Trade: What’s next for Allarity Therapeutics Inc. stockJuly 2025 Decliners & Low Risk Growth Stock Ideas - خودرو بانک
What the charts say about Allarity Therapeutics Inc. todayWeekly Profit Report & Safe Capital Growth Stock Tips - newser.com
Published on: 2025-09-17 19:56:52 - خودرو بانک
Guidance Update: Will Allarity Therapeutics Inc stock recover after earningsMarket Performance Recap & Technical Analysis for Trade Confirmation - خودرو بانک
Market Review: Is Allarity Therapeutics Inc stock good for income investorsJuly 2025 Macro Moves & Technical Confirmation Alerts - خودرو بانک
Applying Wyckoff theory to Allarity Therapeutics Inc. stockJuly 2025 Levels & Expert Verified Movement Alerts - newser.com
Market Catalysts: Is Allarity Therapeutics Inc backed by strong institutional buying2025 Top Gainers & Consistent Profit Trading Strategies - خودرو بانک
Published on: 2025-09-16 05:52:14 - khodrobank.com
Is now a turning point for Allarity Therapeutics Inc.2025 Market Outlook & Verified Momentum Stock Alerts - newser.com
What is Allarity Therapeutics Inc. s P E ratio telling usRisk Management & Intraday High Probability Alerts - khodrobank.com
Downgrade Watch: Will Allarity Therapeutics Inc stock recover after earningsInsider Buying & Low Volatility Stock Suggestions - خودرو بانک
Quarterly Earnings: What is Allarity Therapeutics Inc. s P E ratio telling usWeekly Trade Report & Fast Gain Swing Trade Alerts - خودرو بانک
Buyback Watch: Is ADSE forming a breakout patternJuly 2025 Volume & Long-Term Investment Growth Plans - خودرو بانک
Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer - Investing News Network
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships - Investing News Network
What is Allarity Therapeutics Inc. s 5 year growth outlook2025 Buyback Activity & Reliable Entry Point Trade Alerts - Lancaster City Council
Will Allarity Therapeutics Inc. outperform during market rallies2025 Top Gainers & Safe Entry Zone Tips - Lancaster City Council
Should you avoid Allarity Therapeutics Inc. stock right nowJuly 2025 Review & Low Risk Entry Point Tips - Lancaster City Council
What is Allarity Therapeutics Inc.’s book value per shareMarket Volume Report & AI Driven Stock Price Forecasts - beatles.ru
Is Allarity Therapeutics Inc. in a bullish channel2025 Institutional Moves & AI Driven Stock Movement Reports - 뉴스영
Should I average down on Allarity Therapeutics Inc. stock2025 Earnings Surprises & Risk Adjusted Swing Trade Ideas - خودرو بانک
Finanzdaten der Allarity Therapeutics Inc-Aktie (ALLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):